Silicon Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 117.10 Cr
as on 17-01-2025
- Paid Up Capital ₹ 109.97 Cr
as on 17-01-2025
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 45.00 Cr
as on 17-01-2025
- Revenue 30.61%
(FY 2020)
- Profit -21.54%
(FY 2020)
- Ebitda 12.02%
(FY 2020)
- Net Worth 34.12%
(FY 2020)
- Total Assets -15.12%
(FY 2020)
About Silicon Life Sciences
- CIN/LLPIN
U85100TG2008PTC057669
- Company No.
057669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2008
- Date of AGM
24 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Silicon Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryanarayana Mula  | CFO | 23-May-2019 | Current |
| Venkata Racharla | Company Secretary | 15-Apr-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Kambam | Director | 30-Aug-2013 | Current |
| Venkateswararao Kondreddy | Director | 28-Feb-2018 | Current |
| Jacob Joseph | Whole-Time Director | 23-May-2019 | Current |
| Sapna | Director | 23-May-2019 | Current |
Financial Performance of Silicon Life Sciences.
Silicon Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 30.61% increase. The company also saw a substantial fall in profitability, with a 21.54% decrease in profit. The company's net worth Soared by an impressive increase of 34.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silicon Life Sciences?
In 2020, Silicon Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Apl Healthcare LimitedActive 18 years 1 month
Nityananda Kambam and Suryanarayana Mula are mutual person
- Raidurgam Developers LimitedActive 12 years 6 months
Nityananda Kambam and Venkateswararao Kondreddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 18 Feb 2016 | ₹15.00 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 02 Jul 2011 | ₹30.00 Cr | Satisfied |
How Many Employees Work at Silicon Life Sciences?
Unlock and access historical data on people associated with Silicon Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silicon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silicon Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
